Bradmer Pharmaceuticals Inc. (TSX VENTURE:BMR.H) announced today that it has
granted, subject to regulatory approval, options to directors and officers of
the company exercisable to acquire an aggregate of 1,500,000 common shares, at a
price of $0.10 per share, expiring July 21, 2021.
Grafico Azioni Bradmer Pharmaceuticals (TSXV:BMR.H)
Storico
Da Mag 2024 a Giu 2024 Clicca qui per i Grafici di Bradmer Pharmaceuticals
Grafico Azioni Bradmer Pharmaceuticals (TSXV:BMR.H)
Storico
Da Giu 2023 a Giu 2024 Clicca qui per i Grafici di Bradmer Pharmaceuticals